Medical Cannabis, Inc. Subsidiary Kannaway ® Supports European Industrial Hemp Association in Opinion Letter on Legal Status of CBD and Hemp
SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE)– via NEWMEDIAWIRE– Medical Marijuana, Inc.( OTC: MJNA) (the “Business”), the first-ever publicly traded cannabis business in the United States that introduced the world’s first-ever cannabis-derived nutraceutical items, brand names and supply chain, announced today that its subsidiary Kannaway ® is proud to support the European Industrial Hemp Association (EIHA) in its current viewpoint letter to the European Commission on the legal status of cannabidiol (CBD) and hemp.
EIHA’s letter was composed in reaction to the European Commission’s choice to suspend all applications for hemp extracts and natural cannabinoids under the European Union’s Novel Food rules and also consider under a “initial conclusion” that extracts from the flowering and fruiting tops of the hemp plant need to be thought about a drug under the United Nations Single Convention on Narcotic Drugs of1961 EIHA explains that the decision is “not based upon the current clinical literature nor inspired by the present debate at the United Nations level.”
EIHA believes that industrial hemp and its downstream products are not narcotic or psychotropic drugs. Hemp is excused from the scope of the United Nations Single Convention of 1961, which features a clear distinction between cannabis varieties grown for the production of drugs and exempting marijuana grown for any other purpose (with low levels of THC).
” Hemp has actually been a food source for centuries and for decades the EU has actually stated that hemp extracts are not novel. It appears like a political relocate to now try to change its legal status,” stated Kannaway ® Handling Director of International Janne Heimonen. “There is terrific consumer demand for items and hemp farming supports the EU’s ambitious sustainability objectives. We are fully committed to helping the industry keep offering customers the items they require.”
Kannaway ® has led the CBD market in Europe considering that2018 In December 2019, Kannaway ® executives spoke in the European Parliament at a special event on “The State of Hemp in Europe” about how to improve the European hemp market for all of its applications consisting of CBD items.
” Kannaway has actually pioneered the hemp CBD market in Europe and plans to continue to grow its robust market there,” said Kannaway ® CEO Blake Schroeder. “Our portfolio of Business has actually worked with federal government leaders around the globe to make certain that individuals have legal access to CBD and we will do the very same in Europe.”
For more information about Kannaway ®, please check out http://www.kannaway.com
Kannaway ® is a network sales and marketing business focusing on the sales and marketing of hemp-based botanical products. Kannaway ® currently hosts weekly online sales meetings and conferences throughout the United States, offering special insight and chance to sales professionals who are desirous of becoming effective leaders in the sale and marketing of hemp-based botanical products.
About Medical Cannabis, Inc.
We are a business of firsts ® Medical Cannabis, Inc. ( MJNA) is a cannabis business with 3 unique organisation units in the non-psychoactive cannabinoid area: a worldwide portfolio of cannabinoid-based nutraceutical brands led by Kannaway ® and HempMeds ® ; a leader in sourcing the highest-quality legal non-psychoactive cannabis items originated from industrial hemp; and a cannabinoid-based scientific research and botanical drug advancement sector led by its pharmaceutical investment firm and partners consisting of AXIM ® Biotechnologies, Inc and Kannalife, Inc Medical Marijuana, Inc. was called a top CBD producer by CNBC Medical Cannabis, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of international markets. The business’s flagship product Genuine Scientific Hemp Oil has actually been utilized in several successful scientific studies throughout Mexico and Brazil to comprehend its security and efficacy.
Medical Cannabis, Inc.’s head office remains in San Diego, California, and additional info is offered at OTCMarkets.com or by checking out www.medicalmarijuanainc.com To see Medical Marijuana, Inc.’s business video, click on this link
Shareholders and consumers are likewise encouraged to buy CBD oil and other items at Medical Marijuana, Inc.’s store.
This news release might contain particular forward-looking statements and details, as specified within the meaning of Section 27 A of the Securities Act of 1933 and Area 21 E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor produced by those areas. This product includes declarations about predicted future occasions and/or financial results that are forward-looking in nature and topic to dangers and uncertainties. Such forward-looking declarations by definition involve threats, unpredictabilities and other elements, which might cause the actual outcomes, performance or achievements of Medical Cannabis, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These declarations have actually not been examined by the Food and Drug Administration. This item is not meant to diagnose, deal with, treat, or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute any items that are in violation of the United States Controlled Substances Act.
Financier Relations Contact:
P. (858) 283-4016